HEMO could break up from hereCorrection could be complete here and this would be the bottom of the channel from the start of this move up. Targets are still well above the 20p region, a great place to start accumulating. If it breaks down the Y wave should end in the 7.7-7.9p region. I dont see that coming based on dropping vol
−3.98 MGBP
1.22 B
About HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01
Sector
Industry
CEO
Vladislav Sandler
Website
Headquarters
London
Employees (FY)
22
Founded
2012
ISIN
GB00BYX3WZ24
FIGI
BBG00BDKH4D5
HemoGenyx Pharmaceuticals Plc operates as a biopharmaceutical company, which engages in the development of novel therapies to transform bone marrow and blood stem cell transplantation. It provides treatment for blood diseases such as leukaemia, lymphoma and blood marrow failure. The company's novel therapies are used in the preparation of patients for transplantation such as chemotherapy and radiation treatments, and will address the problem of finding a matching stem cell donor and reduce the risk of blood stem cell rejection after transplantation. Its products include CDX Bi-Specific Antibodies; and Human Postnatal Hemogenic Endothelial Cells. HemoGenyx Pharmaceuticals was founded by Alexis M. Sandler and Vladislav Sandler in 2012 and is headquartered in London, the United Kingdom.
HEMO - in move to wave 3Massive winner today Hemogenyx (HEMO) moved 55% in 1.5h before market close on the news drop of working closely and in agreement with Eli Lilly. The correction has been clearly completed and there were already signs of this impulse up with the sub wave 1 and then sub wave 2 correction days ago. The
Hemogenyx has much more in this bull runFrom the 7,5p range this will burst off towards 15p previous top target. The news of the collaboration with GlobalCo is reinforced and is confirmed to be a positive collaboration based on expected outcome. We expect something materialised out of it in 3 months. Therefore the upside potential is rema
Hemogenyx will pump nextI see 5th leg of the Wave 3 is still missing, touched this trendline and expected to pump more.
News are due potential is big as always, but more importantly buyers are lining up, Selling volume is constantly declining on dropping price which means accumulation and a rocket sign. Multibag potential
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HEMO is 1.664 GBX — it has increased by 2.14% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 stocks are traded under the ticker HEMO.
HEMO stock is 4.94% volatile and has beta coefficient of −1.75. Check out the list of the most volatile stocks — is HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 there?
Yes, you can track HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 financials in yearly and quarterly reports right on TradingView.
HEMO stock has risen by 3.67% compared to the previous week, the month change is a 2.84% fall, over the last year HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 has showed a 15.71% decrease.
Today HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 has the market capitalization of 21.86 M, it has increased by 0.94% over the last week.
No, HEMO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HEMO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 22.00 employees. See our rating of the largest employees — is HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 stock shows the sell signal. See more of HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.